Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02419755
Title Bortezomib and Vorinostat in Younger Patients With Refractory or Relapsed MLL Rearranged Hematologic Malignancies
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors St. Jude Children's Research Hospital
Indications

hematologic cancer

Therapies

Cytarabine

Mercaptopurine

Methotrexate

Pegaspargase

Vorinostat

Doxorubicin

Bortezomib

Dexamethasone

Mitoxantrone

Prednisone

Age Groups: child
Covered Countries USA

Additional content available in CKB BOOST